PDEA, DDB AND PEZA SIGN MOA  to improve registration of licenses and permits  for CPECs in economic zones

PR2232016The Philippine Drug Enforcement Agency (PDEA), the Dangerous Drugs Board (DBB) and the Philippine Economic Zone Authority (PEZA) signed a Memorandum of Agreement (MOA) that sealed their partnership to ensure compliance for application of licenses and permits for controlled precursors and essential chemicals (CPECs) in the economic zones.

The signatories were PDEA Director General Undersecretary Arturo G Cacdac, Jr., Undersecretary Jose Marlowe Pedregosa, Executive Director, DDB, and Director General Lilia De Lima of PEZA who inked the agreement in a ceremony held on May 3, 2016 at 10:00 am in PEZA Building 5, Government Office, Taguig, Bonifacio Global City, Metro Manila.

PDEA, through its Compliance Service under Director Helen Maita Reyes, DDB and PEZA are ISO 9001:2008 certified and thus, the MOA aims to continually improve their services through active cooperation by initiating measures to streamline procedures, processes and guidelines in the timely issuance and approval of license or permit of controlled substances, with the end in view of reducing the cost of doing business in the Philippines.

“The MOA aspires to interface these registration processes cognizant of the trends in ease of doing business in the country and to foster customer satisfaction, which in turn, will contribute significantly in greater production for export by PEZA-registered locator enterprises, a significant number of them are in the Fortune Top 500, or in the Philippines’ Top 1,000 Corporation,” Cacdac said.

PEZA is a government agency that promotes the establishment of special economic zones in the fields of agro-industrial, IT parks and centers, manufacturing, medical tourism and tourism in the Philippines, for foreign investments.

PEZA also monitors the movement of goods and people in the economic zones, and conducts regular inspection to facilities of locator enterprises to ensure compliance with government rules and regulations and that there are no clandestine operations within the zones.

“This tripartite agreement is a step forward in achieving a new partnership that would help strengthen a globally competitive environment for the country’s export-oriented manufacturing industry through efficient drug prevention and control,” Cacdac added.